These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31719596)

  • 1. Atrial Fibrillation in the Elderly: The Role of Sub-Clinical Isolated Cardiac Amyloidosis.
    Krishnappa D; Dykoski R; Can I; Mbai M; Anand IS; Florea V; Chandrashekar YS; Li JM; Tholakanahalli VN
    Sci Rep; 2019 Nov; 9(1):16584. PubMed ID: 31719596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation.
    Leone O; Boriani G; Chiappini B; Pacini D; Cenacchi G; Martin Suarez S; Rapezzi C; Bacchi Reggiani ML; Marinelli G
    Eur Heart J; 2004 Jul; 25(14):1237-41. PubMed ID: 15246642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrillation and subtype of atrial fibrillation in cardiac amyloidosis: clinical and echocardiographic features, impact on mortality.
    Sanchis K; Cariou E; Colombat M; Ribes D; Huart A; Cintas P; Fournier P; Rollin A; Carrié D; Galinier M; Maury P; Duparc A; Lairez O;
    Amyloid; 2019 Sep; 26(3):128-138. PubMed ID: 31172799
    [No Abstract]   [Full Text] [Related]  

  • 4. Patterns of isolated atrial amyloid: a study of 100 hearts on autopsy.
    Steiner I; Hájková P
    Cardiovasc Pathol; 2006; 15(5):287-290. PubMed ID: 16979036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial electrofunctional predictors of incident atrial fibrillation in cardiac amyloidosis.
    Sinigiani G; De Michieli L; Porcari A; Zocchi C; Sorella A; Mazzoni C; Bisaccia G; De Luca A; Di Bella G; Gregori D; Perfetto F; Merlo M; Sinagra G; Iliceto S; Perazzolo Marra M; Corrado D; Ricci F; Cappelli F; Cipriani A
    Heart Rhythm; 2024 Jun; 21(6):725-732. PubMed ID: 38309449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial Fibrillation in Transthyretin Cardiac Amyloidosis: Predictors, Prevalence, and Efficacy of Rhythm Control Strategies.
    Donnellan E; Wazni OM; Hanna M; Elshazly MB; Puri R; Saliba W; Kanj M; Vakamudi S; Patel DR; Baranowski B; Cantillon D; Dresing T; Jaber WA
    JACC Clin Electrophysiol; 2020 Sep; 6(9):1118-1127. PubMed ID: 32972546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart failure with preserved ejection fraction, atrial fibrillation, and the role of senile amyloidosis.
    van den Berg MP; Mulder BA; Klaassen SHC; Maass AH; van Veldhuisen DJ; van der Meer P; Nienhuis HLA; Hazenberg BPC; Rienstra M
    Eur Heart J; 2019 Apr; 40(16):1287-1293. PubMed ID: 30753432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study.
    Zakeri R; Chamberlain AM; Roger VL; Redfield MM
    Circulation; 2013 Sep; 128(10):1085-93. PubMed ID: 23908348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial fibrillation, the arrhythmia of the elderly, causes and associated conditions.
    Levy S
    Anadolu Kardiyol Derg; 2002 Mar; 2(1):55-60. PubMed ID: 12101796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter.
    Ahmari SA; Bunch TJ; Chandra A; Chandra V; Ujino K; Daly RC; Kushwaha SS; Edwards BS; Maalouf YF; Seward JB; McGregor CG; Chandrasekaran K
    J Heart Lung Transplant; 2006 Jan; 25(1):53-60. PubMed ID: 16399531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial amyloidosis: an arrhythmogenic substrate for persistent atrial fibrillation.
    Röcken C; Peters B; Juenemann G; Saeger W; Klein HU; Huth C; Roessner A; Goette A
    Circulation; 2002 Oct; 106(16):2091-7. PubMed ID: 12379579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathological changes in the right atrial appendages triggering atrial fibrillation: A tertiary care center study.
    Shah SN; Varghese RGB; Theodore S
    Indian J Pathol Microbiol; 2021; 64(3):464-468. PubMed ID: 34341254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic significance of atrial fibrillation in heart failure with preserved ejection function: insights from KaRen, a prospective and multicenter study.
    Bosseau C; Donal E; Lund LH; Oger E; Hage C; Mulak G; Daubert JC; Linde C;
    Heart Vessels; 2017 Jun; 32(6):735-749. PubMed ID: 28028584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catheter ablation of atrial fibrillation in cardiac amyloidosis.
    Black-Maier E; Rehorn M; Loungani R; Friedman DJ; Alenezi F; Geurink K; Pokorney SD; Daubert JP; Sun AY; Atwater BD; Jackson KP; Hegland DD; Thomas KL; Bahnson TD; Khouri MG; Piccini JP
    Pacing Clin Electrophysiol; 2020 Sep; 43(9):913-921. PubMed ID: 32573789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telocytes in human isolated atrial amyloidosis: ultrastructural remodelling.
    Mandache E; Gherghiceanu M; Macarie C; Kostin S; Popescu LM
    J Cell Mol Med; 2010 Dec; 14(12):2739-47. PubMed ID: 21040457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and predictors of atrial fibrillation in patients with light-chain or transthyretin cardiac amyloidosis.
    Papathanasiou M; Jakstaite AM; Oubari S; Siebermair J; Wakili R; Hoffmann J; Carpinteiro A; Hagenacker T; Thimm A; Rischpler C; Kessler L; Rassaf T; Luedike P
    ESC Heart Fail; 2022 Jun; 9(3):1740-1748. PubMed ID: 35178887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent atrial fibrillation in heart failure with preserved ejection fraction: Prognostic relevance and association with clinical, imaging and invasive haemodynamic parameters.
    Schönbauer R; Duca F; Kammerlander AA; Aschauer S; Binder C; Zotter-Tufaro C; Koschutnik M; Fiedler L; Roithinger FX; Loewe C; Hengstenberg C; Bonderman D; Mascherbauer J
    Eur J Clin Invest; 2020 Feb; 50(2):e13184. PubMed ID: 31732964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume.
    Lam CS; Rienstra M; Tay WT; Liu LC; Hummel YM; van der Meer P; de Boer RA; Van Gelder IC; van Veldhuisen DJ; Voors AA; Hoendermis ES
    JACC Heart Fail; 2017 Feb; 5(2):92-98. PubMed ID: 28017355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of CHA2DS2-VASc score in patients with 'non-valvular atrial fibrillation' and valvular heart disease: the Loire Valley Atrial Fibrillation Project.
    Philippart R; Brunet-Bernard A; Clementy N; Bourguignon T; Mirza A; Babuty D; Angoulvant D; Lip GY; Fauchier L
    Eur Heart J; 2015 Jul; 36(28):1822-30. PubMed ID: 25994754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of clinical characteristics of patients with heart failure and preserved ejection fraction with atrial fibrillation versus sinus rhythm: Insights from the APOLLON registry.
    Özlek B; Özlek E; Tekinalp M; Kahraman S; Zencirkiran Agus H; Başaran Ö; Kaya BC; Rencüzoğulları İ; Mert KU; Çakır O; Ösken A; Bekar L; Çelik Y; Çil C; Doğan V; Çelik O; Mert GÖ; Memiç Sancar K; Sevinç S; Biteker M
    Turk Kardiyol Dern Ars; 2020 Apr; 48(3):234-245. PubMed ID: 32281959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.